rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Nadir Mahmood

President

Company insider

Files Form 4 as: President, Nkarta.

Every Form 4 they filed

In numbers

Trades disclosed
50
Buys
0
Sells
10
Bought
$0
Sold
$1.1M
Companies
1
Companies where not an officer
0
First trade
9 Jul 2020
Last trade
15 Jan 2026
Last filed
20 Jan 2026

Companies traded

Where they are an officer
NKTX NkartaOfficer · Biotechnology · last 15 Jan 20260 buys · 10 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jan 2026filed 20 Jan 2026NKTX NkartaBiotechnologySEC FORM 4 Sold$12K5,649 at $2.07filing
15 Jan 2026filed 20 Jan 2026NKTX NkartaBiotechnologySEC FORM 4 Sold$12K5,649 at $2.07filing
6 Jan 2026filed 8 Jan 2026NKTX NkartaBiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
6 Jan 2026filed 8 Jan 2026NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code A—160,000 at $0.00filing
6 Jan 2026filed 8 Jan 2026NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code A—160,000 at $0.00filing
6 Jan 2026filed 8 Jan 2026NKTX NkartaBiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
5 Jun 2025filed 9 Jun 2025NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code A—123,500 at $0.00filing
3 Jan 2025filed 7 Jan 2025NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code A—123,500 at $0.00filing
3 Jan 2025filed 7 Jan 2025NKTX NkartaBiotechnologySEC FORM 4 Code A—62,000 at $0.00filing
29 Jul 2024filed 31 Jul 2024NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code A—550,000 at $0.00filing
20 Jun 2023filed 22 Jun 2023NKTX NkartaBiotechnologySEC FORM 4 Sold$2,551526 at $4.85filing
17 Jan 2023filed 18 Jan 2023NKTX NkartaBiotechnologySEC FORM 4 Sold$6,1601,122 at $5.49filing
13 Jan 2023filed 18 Jan 2023NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
13 Jan 2023filed 18 Jan 2023NKTX NkartaBiotechnologySEC FORM 4 Code A—37,500 at $0.00filing
15 Aug 2022filed 17 Aug 2022NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code M—4,819 at $0.00filing
15 Aug 2022filed 17 Aug 2022NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code M—2,681 at $0.00filing
15 Aug 2022filed 17 Aug 2022NKTX NkartaBiotechnologySEC FORM 4 Code M$29K7,500 at $3.89filing
15 Aug 2022filed 17 Aug 2022NKTX NkartaBiotechnologySEC FORM 4 Sold$135K7,500 at $18.03filing
8 Aug 2022filed 10 Aug 2022NKTX Nkartaoption or derivative · BiotechnologySEC FORM 4 Code M—7,500 at $0.00filing
8 Aug 2022filed 10 Aug 2022NKTX NkartaBiotechnologySEC FORM 4 Code M$29K7,500 at $3.89filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care10

Buys in green, sells in red, by the company’s sector.

Related people

Paul J. HastingsChief Executive Officer · Chief Executive Officer at Nkarta, filing Form 4 there in the last year
RA CAPITAL MANAGEMENT, L.P.Director and 10% owner · Director and 10% owner at Nkarta, filing Form 4 there in the last year
Simeon GeorgeDirector · Director at Nkarta, filing Form 4 there in the last year
Michael DybbsDirector · Director at Nkarta, filing Form 4 there in the last year
Ali BehbahaniDirector · Director at Nkarta, filing Form 4 there in the last year